-
Taxonomy & unit
-
dei: USD
-
Description
-
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
-
Summary
-
Nuvectis Pharma, Inc. quarterly Entity Public Float history and growth rate from Q4 2022 to Q4 2023.
- Nuvectis Pharma, Inc. Entity Public Float for the quarter ending December 30, 2023 was $60M, a 6.25% decline year-over-year.
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Growth (%)